{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:10:39Z","timestamp":1761765039441,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de R\u00e9adaptation et de M\u00e9decine Physique"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.annrmp.2008.03.003","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T09:22:00Z","timestamp":1210238520000},"page":"315-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Suivi des patients apr\u00e8s injection de toxine botulique intrad\u00e9trusorienne"],"prefix":"10.1016","volume":"51","author":[{"given":"M.","family":"de S\u00e8ze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruffion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Haab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Chartier-Kastler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Denys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Game","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Karsenty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kerdraon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Perrouin-Verbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Saussine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Amarenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annrmp.2008.03.003_bib1","unstructured":"Anaes. Guide d\u2019analyse de la litt\u00e9rature et gradation des recommandations. Janvier 2000. http:\/\/www.anaes.fr."},{"key":"10.1016\/j.annrmp.2008.03.003_bib2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.apmr.2006.08.345","article-title":"Qualiveen: a urinary disorder-specific instrument for use in clinical trials in multiple sclerosis","volume":"87","author":"Bonniaud","year":"2006","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.annrmp.2008.03.003_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0399-077X(03)00122-7","article-title":"Infections urinaires nosocomiales de l\u2019adulte\u00a0: conf\u00e9rence de consensus 2002, texte court","volume":"33","author":"Botto","year":"2003","journal-title":"Med Mal Inf"},{"key":"10.1016\/j.annrmp.2008.03.003_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2006.01.005","article-title":"Botulinum toxin \u2013 new mechanisms, new therapeutic directions?","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.annrmp.2008.03.003_bib5","first-page":"662","article-title":"Prise en charge urologique des vessies neurog\u00e8nes. Rapport du 11e congr\u00e8s (2006) de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"17","author":"Chartier-Kastler","year":"2007","journal-title":"Prog Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.sc.3101736","article-title":"Adverse events after botulinum\u00a0A toxin injection for neurogenic voiding disorders","volume":"43","author":"De Laet","year":"2005","journal-title":"Spinal Cord"},{"key":"10.1016\/j.annrmp.2008.03.003_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1185\/030079906X104614","article-title":"Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies","volume":"22","author":"Denys","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.annrmp.2008.03.003_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2007.06575.x","article-title":"Botulinum toxin\u00a0A in the overactive bladder: current status and future directions","volume":"99","author":"Dmochowski","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.annrmp.2008.03.003_bib9","doi-asserted-by":"crossref","unstructured":"Duthie J, Wilson DI, Herbison GP, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev 2007, Issue 3. Art. No.: CD005493. DOI: 10.1002\/14651858.CD005493.pub2.","DOI":"10.1002\/14651858.CD005493.pub2"},{"key":"10.1016\/j.annrmp.2008.03.003_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ucl.2004.09.005","article-title":"Injectable neuromodulatory agents: botulinum toxin therapy","volume":"32","author":"Frenkl","year":"2005","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.annrmp.2008.03.003_bib11","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jama.1995.03530220066035","article-title":"IX. A method for grading health care recommendations","volume":"22","author":"Guyatt","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.annrmp.2008.03.003_bib12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","article-title":"Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type\u00a0A and correlations with lower urinary tract symptoms and urodynamic changes","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin\u00a0A intradetrusor injections in adults with neurogenic detrusor overactivity\/overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","article-title":"Persistence of therapeutic effect after repeated injections of botulinum toxin type\u00a0A to treat incontinence due to neurogenic detrusor overactivity","volume":"68","author":"Karsenty","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.annrmp.2008.03.003_bib15","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type\u00a0A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.annrmp.2008.03.003_bib16","first-page":"198","article-title":"Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art","volume":"8","author":"Nitti","year":"2006","journal-title":"Rev Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","article-title":"Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results","volume":"50","author":"Patel","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.ju.0000108844.10235.f1","article-title":"Botulinum toxin type\u00a0B for type\u00a0A resistant bladder spasticity","volume":"171","author":"Pistolesi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S1166-7087(07)92346-5","article-title":"Urinary tract infection and neurogenic bladder","volume":"17","author":"Salomon","year":"2007","journal-title":"Prog Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.annrmp.2008.03.003_bib23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2165\/00003495-200666100-00001","article-title":"Botulinum toxin for the management of bladder dysfunction","volume":"66","author":"Schurch","year":"2006","journal-title":"Drugs"}],"container-title":["Annales de R\u00e9adaptation et de M\u00e9decine Physique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168605408000652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168605408000652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:59:41Z","timestamp":1759172381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168605408000652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0168605408000652"],"URL":"https:\/\/doi.org\/10.1016\/j.annrmp.2008.03.003","relation":{},"ISSN":["0168-6054"],"issn-type":[{"type":"print","value":"0168-6054"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suivi des patients apr\u00e8s injection de toxine botulique intrad\u00e9trusorienne","name":"articletitle","label":"Article Title"},{"value":"Annales de R\u00e9adaptation et de M\u00e9decine Physique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annrmp.2008.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}